Demant A/S (OTCMKTS:WILYY – Get Rating) has earned an average recommendation of “Hold” from the six analysts that are currently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company.
A number of brokerages recently weighed in on WILYY. JPMorgan Chase & Co. upgraded shares of Demant A/S from an “underweight” rating to a “neutral” rating in a research report on Tuesday, January 4th. Jefferies Financial Group began coverage on shares of Demant A/S in a report on Thursday, April 21st. They set a “buy” rating on the stock.
Shares of OTCMKTS:WILYY opened at $22.22 on Thursday. The firm’s 50 day simple moving average is $21.11 and its 200 day simple moving average is $22.85. Demant A/S has a fifty-two week low of $18.60 and a fifty-two week high of $30.02.
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products.
- Get a free copy of the StockNews.com research report on Demant A/S (WILYY)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- O’Reilly Automotive Hits A Pothole
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.